Rapid determination of ADAMTS13 activity improves clinical decision-making

被引：2
|
作者：
Cataland, Spero R. [1 ]
Jin, Ming
Wu, Haifeng M.
机构：
[1] Ohio State Univ, Dept Med, Div Hematol Oncol, Med Ctr, Columbus, OH 43210 USA
[2] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2007年 / 82卷 / 03期
关键词：
D O I：
10.1002/ajh.20746
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：251 / 251
页数：1
相关论文
共 50 条
  • [41] Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse
    Jin, Ming
    Casper, T. Charles
    Cataland, Spero R.
    Kennedy, Melanie S.
    Lin, Shili
    Li, Yu J.
    Wu, Haifeng M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (05) : 651 - 658
  • [42] Adenoviral-mediated gene transfer restores plasma ADAMTS13 antigen and activity in ADAMTS13 knockout mice
    Trionfini, P.
    Tomasoni, S.
    Galbusera, M.
    Motto, D.
    Longaretti, L.
    Corna, D.
    Remuzzi, G.
    Benigni, A.
    GENE THERAPY, 2009, 16 (11) : 1373 - 1379
  • [43] Adenoviral-mediated gene transfer restores plasma ADAMTS13 antigen and activity in ADAMTS13 knockout mice
    P Trionfini
    S Tomasoni
    M Galbusera
    D Motto
    L Longaretti
    D Corna
    G Remuzzi
    A Benigni
    Gene Therapy, 2009, 16 : 1373 - 1379
  • [44] Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA)
    Rieger, M
    Ferrari, S
    Hovinga, JAK
    Konetschny, C
    Herzog, A
    Koller, L
    Weber, A
    Remuzzi, G
    Dockal, M
    Plaimauer, B
    Scheiflinger, F
    THROMBOSIS AND HAEMOSTASIS, 2006, 95 (02) : 212 - 220
  • [45] Falsely low ADAMTS13 activity caused by levofloxacin
    Nixon, Christian P.
    Guertin, Christine
    Sweeney, Joseph D.
    TRANSFUSION, 2019, 59 (08) : 2752 - 2753
  • [46] The Potential Therapeutic Benefit of Targeting ADAMTS13 Activity
    Eerenberg, Elise S.
    Levi, Marcel
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (01): : 28 - 33
  • [47] Clinical utility of ADAMTS13 biomarkers in the evaluation of TTP
    Wu, H.
    Cataland, S.
    TRANSFUSION, 2008, 48 (02) : 256A - 256A
  • [48] The Clinical Implications of ADAMTS13 Function: The Perspectives of Haemostaseologists
    Rangarajan, Savita
    Kessler, Craig
    Aledort, Louis
    THROMBOSIS RESEARCH, 2013, 132 (04) : 403 - 407
  • [49] Evaluation of a commercial assay for ADAMTS13 activity measurement
    Thouzeau, Sandrine
    Capdenat, Sophie
    Stepanian, Alain
    Coppo, Paul
    Veyradier, Agnes
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (04) : 852 - 853
  • [50] Cleavage of the ADAMTS13 propeptide is not required for protease activity
    Majerus, EM
    Zheng, XL
    Tuley, EA
    Sadler, JE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) : 46643 - 46648
12345